Global Custom Market Research Reports Provider Company

phone

Haematology Analyzers - Medical Devices Pipeline Assessment, 2017

  • Published Date: 09 Aug 2017
  • Number of Pages: 151
  • Category: Healthcare and Medical
  • Country: Global
Haematology Analyzers - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Haematology Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Haematology Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Haematology Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Haematology Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Haematology Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Haematology Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Haematology Analyzers Overview 8
3 Products under Development 9
3.1 Haematology Analyzers - Pipeline Products by Stage of Development 9
3.2 Haematology Analyzers - Pipeline Products by Territory 10
3.3 Haematology Analyzers - Pipeline Products by Regulatory Path 11
3.4 Haematology Analyzers - Pipeline Products by Estimated Approval Date 12
3.5 Haematology Analyzers - Ongoing Clinical Trials 13
4 Haematology Analyzers - Pipeline Products under Development by Companies 14
4.1 Haematology Analyzers Companies - Pipeline Products by Stage of Development 14
4.2 Haematology Analyzers - Pipeline Products by Stage of Development 15
5 Haematology Analyzers Companies and Product Overview 16
5.1 Abbott Diagnostics Company Overview 16
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Analyticon Biotechnologies AG Company Overview 17
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Apollo Medical Devices LLC Company Overview 19
5.3.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Auer Precision Company Overview 20
5.4.1 Auer Precision Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Cell.Copedia GmbH Company Overview 21
5.5.1 Cell.Copedia GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 Cellmic LLC Company Overview 22
5.6.1 Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Chromedx Corp Company Overview 23
5.7.1 Chromedx Corp Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 DiaSorin S.p.A Company Overview 25
5.8.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Diatron Medical Instruments Limited Company Overview 27
5.9.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 Drew Scientific Co Ltd Company Overview 29
5.10.1 Drew Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Immucor, Inc. Company Overview 30
5.11.1 Immucor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 IRIS International Inc Company Overview 32
5.12.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Mindray Medical International Ltd Company Overview 33
5.13.1 Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
5.14 Nova Biomedical Corp Company Overview 35
5.14.1 Nova Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Quotient Limited Company Overview 36
5.15.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 36
5.16 Redbud Labs Inc Company Overview 39
5.16.1 Redbud Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.17 Siemens Healthcare GmbH Company Overview 40
5.17.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
5.18 SigTuple Technologies Private Limited Company Overview 41
5.18.1 SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 41
5.19 SpinChip Diagnostics AS Company Overview 42
5.19.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 42
5.20 University of British Columbia Company Overview 43
5.20.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 43
6 Haematology Analyzers- Recent Developments 44
6.1 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 44
6.2 Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 44
6.3 Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 45
6.4 Aug 02, 2017: Sysmex America Offers Live Demonstrations at AACC 2017 46
6.5 Jul 31, 2017: ChroMedX Works Towards Third Version of HemoPalm Prototype Analyzer 47
6.6 Jul 31, 2017: Sysmex America Completes Expansion of Reagents Manufacturing Facility, Opens Doors to Latin American Sales Office in Doral, Florida 47
6.7 Jul 27, 2017: Abaxis Reports Financial Performance for the First Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend 47
6.8 Jul 25, 2017: ERBA Diagnostics Appoints David Barka as Interim Chief Executive Officer, Nikhil Vazirani as Member of the Board 49
6.9 Jul 21, 2017: Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ and Fiscal First Quarter 2018 Financial Results and Host Conference Call 49
6.10 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 50
6.11 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 52
6.12 Jul 18, 2017: CellaVision: Strong second quarter with growth and increased profitability 53
6.13 Jul 11, 2017: Sysmex America Announces Launch of XN-L Automated Hematology Analyzers in U.S. 54
6.14 Jun 29, 2017: Daxor Holds Annual Meeting, Provides Business Growth Update and Strategic Plan 55
6.15 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 56
6.16 Jun 22, 2017: Haemonetics Announces Formation of Scientific Advisory Council 57
6.17 Jun 14, 2017: Abbott Introduces the Alinity hq Hematology Analyzer, the Newest Addition to the Alinity Family of Harmonized Systems 58
6.18 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 59
6.19 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 59
6.20 May 31, 2017: Daxor Announces Hiring of Chief Financial Officer 60
6.21 May 25, 2017: Magellan Diagnostics Recalls LeadCare Plus Testing System Due to Inaccurate Test Results 60
6.22 May 25, 2017: Magellan Diagnostics Recalls LeadCare Ultra Testing System Due to Inaccurate Test Results 61
6.23 May 22, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results 62
6.24 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 63
6.25 May 19, 2017: ChroMedX Completes HemoPalm System Prototype 64
6.26 May 17, 2017: FDA warns Americans about risk of inaccurate results from certain lead tests 65
6.27 May 08, 2017: ChroMedX Completes Receptor Component and Commences Packaging of HemoPalm Analyzer Prototype 66
6.28 May 08, 2017: Haemonetics Reports 4th Quarter and Fiscal Year 2017 Results and Provides Fiscal 2018 Guidance 67
6.29 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 69
6.30 May 02, 2017: Medline Names New President of Canadian Business 70
6.31 May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 71
6.32 May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 72
6.33 Apr 27, 2017: Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend 73
6.34 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 73
6.35 Apr 24, 2017: ChroMedX Files Enhanced Patent on Cartridge Improvements;Extends Protection to 2037 75
6.36 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 75
6.37 Apr 10, 2017: Daxor Announces Delay in Filing of Form N-CSR for December 31, 2016, and the Uniformed Services University of Health Sciences has been awarded a grant to study hemodilution utilizing Daxors BVA-100 device 78
6.38 Apr 10, 2017: ChroMedX Finalizes Cartridge For HemoPalm Prototype 78
6.39 Apr 07, 2017: Nova Biomedical Obtains CE Mark Certification for Allegro Analyzer 79
6.40 Apr 07, 2017: CellaVision quantifies the outlook for the first quarter of 2017; Sales exceeding SEK 93 million in the first quarter of 2017 79
6.41 Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities 80
6.42 Apr 01, 2017: New Release of H30 Fully Automated Hematology Analyzer 80
6.43 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston 80
6.44 Mar 30, 2017: Quotient Reports Continued Positive MosaiQ Performance Evaluation Results 82
6.45 Mar 29, 2017: Sysmex America Announces Leadership Promotions 84
6.46 Mar 20, 2017: EKF Diagnostics Holdings: Final results 85
6.47 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 85
6.48 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 87
6.49 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 89
6.50 Mar 09, 2017: Alere Provides Update on Arriva Medical 89
6.51 Mar 06, 2017: Medline Announces New Chief Marketing Officer 90
6.52 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 90
6.53 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 92
6.54 Feb 20, 2017: Sysmex America to Distribute Erythrocyte Sedimentation Rate Products from Alifax 94
6.55 Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 95
6.56 Feb 09, 2017: Quotient Announces Appointment of Christopher Lindop as Chief Financial Officer 97
6.57 Feb 07, 2017: CellaVision: January-December 2016 97
6.58 Feb 06, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Third Quarter Fiscal 2017 Financial Results 100
6.59 Jan 31, 2017: John Adamou Named Vice President of Corporate & Business Development at rHEALTH and DNA Medicine Institute 102
6.60 Jan 30, 2017: SCCM17 Randomized Controlled Trial Analysis: Individualized Volume Management Guided by Direct Blood Volume Analysis (BVA) Sharply Lowers Early ICU Mortality vs Pulmonary Artery Catheter Alone 102
6.61 Jan 26, 2017: Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2017, Declares Quarterly Cash Dividend 103
6.62 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 105
6.63 Jan 10, 2017: Abaxis Reports Preliminary Financial Performance For The Third Quarter Of Fiscal 2017 105
6.64 Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 106
6.65 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 106
6.66 Jan 04, 2017: Alere Provides Update on Arriva Medical 107
6.67 Jan 03, 2017: Apollo Medical Devices Receives NIH and NSF Awards to Develop its Portable Blood Analysis System 107
6.68 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest 108
6.69 Dec 28, 2016: Alere Provides Update on Arriva Medical 108
6.70 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 109
6.71 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 110
6.72 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 110
6.73 Dec 02, 2016: ChroMedX Collaboration with Biointerface Institute Receives OCE Grant for HemoPalm Biosensor Development 111
6.74 Nov 29, 2016: ChroMedX Receives Computer Interface and Co-oximetry Modules for Prototype Assembly 112
6.75 Nov 29, 2016: ERBA Diagnostics names interim CEO 113
6.76 Nov 25, 2016: ChroMedX Commences Biosensor Testing 113
6.77 Nov 22, 2016: ChroMedX Files Global Patent Protection on HemoPalm Handheld Blood Analyzer System 114
6.78 Nov 18, 2016: Daxor Announces Patent Approval, Title Change 114
6.79 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016 115
6.80 Nov 08, 2016: Immucor Announces CE Mark in Europe for Echo Lumena; Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs 116
6.81 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 117
6.82 Nov 02, 2016: Quotient Announces CFO Transition 117
6.83 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 117
6.84 Nov 01, 2016: T2 Biosystems Reports Third Quarter Results 118
6.85 Oct 31, 2016: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ 120
6.86 Oct 31, 2016: Quotient Second Quarter Fiscal 2017 Financial Results 121
6.87 Oct 31, 2016: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Second Quarter Fiscal 2017 Financial Results 123
6.88 Oct 27, 2016: CellaVision: Interim report January-September 2016 125
6.89 Oct 27, 2016: Catherine M. Burzik Joins Haemonetics Board of Directors 126
6.90 Oct 25, 2016: Abaxis Reports Financial Performance For The Second Quarter Of Fiscal 2017 127
6.91 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 129
6.92 Oct 24, 2016: Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market 131
6.93 Oct 22, 2016: FDA Clears ORTHO VISION Max Analyzer for High-Volume Transfusion Medicine Labs 132
6.94 Oct 21, 2016: Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results 133
6.95 Oct 21, 2016: Antoinette Gawin Joins Terumo BCT as Executive Vice President, Global Commercial 133
6.96 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 134
6.97 Oct 19, 2016: Sysmex Canada Announces Launch of XN-L Series Hematology Analyzers 137
6.98 Oct 17, 2016: New design of hematology and clinical chemistry analyzers 137
6.99 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 137
6.100 Oct 11, 2016: FDA analyses conclude that Xarelto clinical trial results were not affected by faulty monitoring device 138
6.101 Oct 04, 2016: Apollo Medical Devices was awarded a $25K Grant 138
6.102 Sep 29, 2016: Two New Studies from the Mayo Clinic and Lankenau Medical Center Presented at Heart Failure Society of America 2016 Highlight Unique Ability of BVA to Identify High Risk at Discharge in Hospitalized Heart Failure Patients 139
6.103 Sep 21, 2016: Beckman Coulter Diagnostics Launches Compact DxH 500 Hematology Analyzer in India 140
6.104 Sep 21, 2016: Beckman Coulter Diagnostics Launches Compact DxH500 Hematology Analyzer in India 141
6.105 Sep 19, 2016: Beckman Coulter installs UKs first DxH 500 compact haematology analyser at University of Chester Institute of Medicine 141
6.106 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 142
6.107 Sep 08, 2016: Quotient Announces Successful Validation of the Initial Manufacturing System for MosaiQ Microarrays 145
6.108 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 146
6.109 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 146
7 Appendix 148
7.1 Methodology 148
7.2 About GlobalData 151
7.3 Contact Us 151
7.4 Disclaimer 151

List Of Tables


Table 1: Haematology Analyzers - Pipeline Products by Stage of Development 9
Table 2: Haematology Analyzers - Pipeline Products by Territory 10
Table 3: Haematology Analyzers - Pipeline Products by Regulatory Path 11
Table 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date 12
Table 5: Haematology Analyzers - Ongoing Clinical Trials 13
Table 6: Haematology Analyzers Companies - Pipeline Products by Stage of Development 14
Table 7: Haematology Analyzers - Pipeline Products by Stage of Development 15
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 16
Table 9: Next Generation Hematology Analyzer - Product Status 16
Table 10: Next Generation Hematology Analyzer - Product Description 16
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 17
Table 12: Hemolyzer 3 Pro - Product Status 17
Table 13: Hemolyzer 3 Pro - Product Description 17
Table 14: Hemolyzer 5 - Product Status 18
Table 15: Hemolyzer 5 - Product Description 18
Table 16: Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: Portable Blood Analysis System - Product Status 19
Table 18: Portable Blood Analysis System - Product Description 19
Table 19: Auer Precision Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: Blood Separation Microfluidic Device - Product Status 20
Table 21: Blood Separation Microfluidic Device - Product Description 20
Table 22: Cell.Copedia GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: CELLina - Product Status 21
Table 24: CELLina - Product Description 21
Table 25: Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 26: LUCAS - Product Status 22
Table 27: LUCAS - Product Description 22
Table 28: Chromedx Corp Pipeline Products & Ongoing Clinical Trials Overview 23
Table 29: HemoPalm - Product Status 23
Table 30: HemoPalm - Product Description 23
Table 31: HemoPalm - Version 3 - Product Status 24
Table 32: HemoPalm - Version 3 - Product Description 24
Table 33: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 25
Table 34: LIAISON IAM - Product Status 25
Table 35: LIAISON IAM - Product Description 26
Table 36: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview 27
Table 37: 3-part Differential Hematology Analyzer - Product Status 27
Table 38: 3-part Differential Hematology Analyzer - Product Description 27
Table 39: Abacus 380 - Product Status 28
Table 40: Abacus 380 - Product Description 28
Table 41: Drew Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: DS360 HbA1c Analyzer - Product Status 29
Table 43: DS360 HbA1c Analyzer - Product Description 29
Table 44: Immucor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: Blood Testing System - Product Status 30
Table 46: Blood Testing System - Product Description 30
Table 47: Echo Lumena - Product Status 31
Table 48: Echo Lumena - Product Description 31
Table 49: IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 50: 3GEMS Hematology Analyzer - Product Status 32
Table 51: 3GEMS Hematology Analyzer - Product Description 32
Table 52: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 53: BC-20s - Product Status 33
Table 54: BC-20s - Product Description 33
Table 55: BC-30s - Product Status 34
Table 56: BC-30s - Product Description 34
Table 57: Nova Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview 35
Table 58: Allegro Analyzer - Product Status 35
Table 59: Allegro Analyzer - Product Description 35
Table 60: Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 36
Table 61: MosaiQ - Product Status 36
Table 62: MosaiQ - Product Description 36
Table 63: Quotient Limited - Ongoing Clinical Trials Overview 37
Table 64: MosaiQ - Clinical Internal Evaluation of MosaiQ for Diagnosis of Blood Transfusion Diseases 38
Table 65: Redbud Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 66: ASAP Device - Product Status 39
Table 67: ASAP Device - Product Description 39
Table 68: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
Table 69: ADCIA 2120 Hematology System - Product Status 40
Table 70: ADCIA 2120 Hematology System - Product Description 40
Table 71: SigTuple Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 41
Table 72: Shonit - Product Status 41
Table 73: Shonit - Product Description 41
Table 74: SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 42
Table 75: SpinChip - Product Status 42
Table 76: SpinChip - Product Description 42
Table 77: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 43
Table 78: Portable Hematology Analyzer - Product Status 43
Table 79: Portable Hematology Analyzer - Product Description 43
Table 80: Glossary 150

List Of Figures


Figure 1: Haematology Analyzers - Pipeline Products by Stage of Development 9
Figure 2: Haematology Analyzers - Pipeline Products by Territory 10
Figure 3: Haematology Analyzers - Pipeline Products by Regulatory Path 11
Figure 4: Haematology Analyzers - Pipeline Products by Estimated Approval Date 12
Figure 5: Haematology Analyzers - Ongoing Clinical Trials 13

This report studies Haematology Analyzers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from

View Report

Haematology Analyzers - Medical Devices Pipeline Assessment, 2017 GlobalDatas Medical Devices sector report, Haematology Analyzers - Medical Devices Pipeline Assessment, 2017 provides an overview of Haematology Analyzers currently in pipeline stage. The

View Report

Immunohaematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 GlobalDatas Medical Devices sector report, Immunohaematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides an overview of Immunohaematology Diagnostic Tests currently

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports